Navigation Links
FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab)
Date:5/29/2009

matology 2008 annual meeting and will be presented at the American Society of Clinical Oncology 2009 annual meeting.

About CLL

CLL is the most common adult leukemia and one of the most common malignant lymphoid diseases. In the United States, about 90,000 people are living with CLL, with approximately 15,000 estimated new cases being diagnosed in 2009. Based on 2007 worldwide estimates, leukemia (all types) accounted for more than 330,000 new cases and more than 245,000 deaths.

CLL cells are malignant B-cells that have a low concentration of CD20 molecules on their surface. B-cells normally protect the body from invading pathogens by developing into plasma cells, which make antibodies. These antibodies directly inactivate pathogens or attach to pathogens to prepare them for destruction by other white blood cells.

About Ofatumumab

Ofatumumab is an investigational monoclonal antibody that targets a membrane-proximal (close to the cell surface), small loop epitope (a portion of a molecule to which an antibody binds) on the CD20 molecule on B-cells. Ofatumumab also binds to the large loop of the CD20 molecule. The CD20 molecule is a key target in CLL therapy because it is highly expressed in most B-cell malignancies.

Ofatumumab is being developed under a collaboration between Genmab and the GSK Oncology and BioPharm R&D Units.

Ofatumumab is not yet approved in any country.

About GlaxoSmithKline (GSK)

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. For company information, visit GlaxoSmithKline at www.gsk.com.

GSK Oncology is dedicated to producing innovations in cancer that
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Advisory Panel Recommends Approval of the SEDASYS(R) System
2. Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
3. FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
4. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
5. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
6. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
7. New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties
8. Arpida Comments on FDAs Anti-infective Drugs Advisory Committee Outcome
9. Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
10. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
11. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Research and Markets has announced the ... Strategic Business Report" report to their offering. ... Hormone Drugs in US$ Million by the following Brands: Humatrope, ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , and Rest of ...
(Date:8/19/2014)... -- Avizia, Inc., a leading provider of cutting-edge telemedicine ... financing round led by NextGen Angels along with Blu ... be used to continue to fuel the rapidly growing ... Edward Kennedy , CEO and president of Tollgrade Communications, ... Kurtzman , CFO of newBrandAnalytics, who joined the board ...
(Date:8/19/2014)... 19, 2014  SCILEX Pharmaceuticals, Inc., a company engaged ... for the treatment of pain, announced that it had formed ... Jeff Gudin , Dr. Charles Argoff , ... Vought . SCILEX Chief Executive Officer ... board would greatly assist in the development and commercialization ...
Breaking Medicine Technology:Global Human Growth Hormone Drugs - Strategic Business Report 2014 2Avizia Closes Funding Round 2SCILEX Pharmaceuticals Announces Scientific Advisory Board 2SCILEX Pharmaceuticals Announces Scientific Advisory Board 3SCILEX Pharmaceuticals Announces Scientific Advisory Board 4
(Date:8/20/2014)... In a recent article published by the ... (UCL) study showed that dental experts from around the ... was the most effective. Analysis of 66 different advice ... frequently recommended, but none were favored by a majority. ... experienced cosmetic dentist Dr. Patrick J. Broome, DMD, ...
(Date:8/20/2014)... 20, 2014 Biosimilars, which are ... approved through an abbreviated process, could reap billions ... Atlantic Information Services, Inc.’s (AIS) Specialty Pharmacy News ... including the Food and Drug Administration’s (FDA) recent ... towards approval. , Drugmaker Sandoz said July 24 ...
(Date:8/20/2014)... August 20, 2014 “Have you recently been ... accident and personal injury lawyer serving the greater Seattle area. ... If so, then keep reading . , In a ... injured in an auto accident can use to see if ... that a personal injury insurance claim will allow an individual ...
(Date:8/20/2014)... August 20, 2014 Low market concentration, ... availability of substitutes typify the market for packaging design ... 3.1 out of 5, indicating a moderate level of ... and suppliers have an equal amount of leverage during ... , First, few substitutes exist for packaging design ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 First ... freestanding emergency rooms in the United States, named Richard ... – FM 685 facility. , “We are pleased ... medical director of our second facility in Pflugerville,” said ... Choice Emergency Room. , Dr. Daniels received his ...
Breaking Medicine News(10 mins):Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3Health News:Five Questions to Determine Who Qualifies for a Personal Injury Claim Recently Released by The Jones Firm in Recent Article 2Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 4Health News:First Choice Emergency Room Announces Dr. Richard Daniels as Medical Director of the Pflugerville – FM 685 Facility 2
... , , MIAMI, ... toys manufactured in China sent parents searching frantically for gifts ... refunds suggested that even so-called educational toys are suspect. Renowned ... are actually harmful to developing brains, retarding language development and ...
... , LONDON, Dec. 7 The National Health ... people in the UK, understands the value of an engaged ... initiative to improve the value of care, many NHS hospitals ... Tanner Company, to train hospital leaders. , "Staff engagement is ...
... , , BOCA RATON, ... the market leader in all-natural herbal and homeopathic remedies for ... as their PR firm of record. The company,s two brands, ... provide complete lines of safe, scientifically-tested, guaranteed products that promote ...
... ... has begun his work as the new worldwide executive director of the Drug Information ... ... MBA, CAE, officially has begun his work as the new worldwide executive director of ...
... , PARSIPPANY, N.J., Dec. 7 Today the Centers for ... Vaccination Week. While the week was designed to highlight the importance ... taking additional steps to keep you and your family healthy during ... , "It,s easy to get overwhelmed by all the information circulating ...
... may be able to reverse some of the damage to ... their cigarettes, according to research out of the University of ... in the December 15 issue of the American Thoracic Society,s ... "We found that exposure to cigarette smoke appears to ...
Cached Medicine News:Health News:Top 10 Toys That Will Scar Your Child for Life 2Health News:The NHS to Improve Patient Care by Better Engaging Staff 2Health News:Native Remedies and PetAlive.com Hires TransMedia Group to Herald Herbal for People and Pets 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 2Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 3Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2
For the quantitative determination of Albumin in serum. Endpoint procedure with Amax at 630 nm. Linearity: to 6 g/dl. Liquid ready-to-use reagent....
ASAT (GOT) FS (IFCC mod). For determination of ASAT (GOT) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
AST (SGOT) reagent is used for the quantitative determination of aspartate aminotransferase (AST) in human serum....
For the quantitative colorimetric determination of AST (SGOT) in serum....
Medicine Products: